The global therapeutic drug monitoring market would expand at a compound annual growth rate (CAGR) of 8.4% from USD 2.30 billion in 2024 to USD 3.44 billion by 2029. The main cause of this increase is ...

Phase I clinical trial of a drug was successfully completed, with promise to treat Alzheimer's and other neurodegenerative diseases. The compound, named VU319, is the first end-to-end drug discovery ...

Recursion Pharmaceuticals, Inc. (“Recursion”) (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced that on December 19, 2024, the ...

A Stanford-led team discovered a new ketosis pathway involving BHB-amino acids, shedding light on its effects like appetite ...

A breakthrough in understanding how a single-cell parasite makes ergosterol (its version of cholesterol) could lead to more ...

Marquis Who's Who honors Adrianne P.S. Smith, MD, for exceptional contributions to wound care and regenerative medicine. Dr. Smith is a seasoned medical professional who has advanced patient care, ...

A breakthrough in understanding how a single-cell parasite makes ergosterol (its version of cholesterol) could lead to more effective drugs for human leishmaniasis, a parasitic disease that afflicts ...

Feeling frisky this festive season? You're not alone. Experts share why hook ups happen when people come home for the ...

The tenth international congress on nanoscience and nanotechnology is scheduled to be held from January 29 to 30 in Rafsanjan ...

For premedication, a combination of an opioid (eg, hydromorphone 0.05-0.1 mg/kg intramuscular [IM] or fentanyl 3 μg/kg) and a ...

Pope and his Cats are ranked No. 4 in the country and bring a 10-1 record into Saturday’s game against the Buckeyes. Ohio ...